EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Mitochondrial dysfunction route as a possible biomarker and therapy target for human cancer

Rawan Al-Faze, Hoda A Ahmed, Mohamed A El-Atawy, Hayat Zagloul, Eida M Alshammari, Mariusz Jaremko, Abdul-Hamid Emwas, Gehan M Nabil, Demiana H Hanna

Biomedical Journal · 2025-02 · 48 (1) · 100714

DOI: 10.1016/j.bj.2024.100714 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomedical Journal, 2025-02. Verfasst von Rawan Al-Faze und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Taibah University, Almadinah Almunawarah, Saudi Arabia. Hauptthemen laut MEDLINE: Mitochondria, Neoplasms, Ovarian Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Education - Kingdom of Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondria are vital organelles found within living cells and have signalling, biosynthetic, and bioenergetic functions. Mitochondria play a crucial role in metabolic reprogramming, which is a characteristic of cancer cells and allows them to ensure a steady supply of proteins, nucleotides, and lipids to enable rapid proliferation and development. Their dysregulated activities have been associated with the growth and metastasis of different kinds of human cancer, particularly ovarian carcinoma. In this review, we briefly demonstrated the modified mitochondrial function in cancer, including mutations in mitochondrial DNA (mtDNA), reactive oxygen species (ROS) production, dynamics, apoptosis of cells, autophagy, and calcium excess to maintain cancer genesis, progression, and metastasis. Furthermore, the mitochondrial dysfunction pathway for some genomic, proteomic, and metabolomics modifications in ovarian cancer has been studied. Additionally, ovarian cancer has been linked to targeted therapies and biomarkers found through various alteration processes underlying mitochondrial dysfunction, notably targeting (ROS), metabolites, rewind metabolic pathways, and chemo-resistant ovarian carcinoma cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaNeoplasmsOvarian NeoplasmsBiomarkers, TumorHumansReactive Oxygen SpeciesFemaleDNA, MitochondrialApoptosis

Stichwörter der Autor:innen

BiomarkersMitochondriaMitochondrial dysfunction pathwayOvarian carcinomaTargeted therapies

Substanzen

Reactive Oxygen SpeciesDNA, MitochondrialBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Science, Taibah University, Almadinah Almunawarah, Saudi Arabia.
  • Chemistry Department, Faculty of Science at Yanbu, Taibah University, Yanbu, Saudi Arabia; Chemistry Department, Faculty of Science, Cairo University, Giza, Egypt.
  • Chemistry Department, Faculty of Science at Yanbu, Taibah University, Yanbu, Saudi Arabia; Chemistry Department, Faculty of Science, Alexandria University, Ibrahemia, Alexandria, Egypt.
  • Chemistry Department, Faculty of Science at Yanbu, Taibah University, Yanbu, Saudi Arabia.
  • Department of Chemistry, College of Sciences, University of Ha'il, Ha'il, Saudi Arabia.
  • Biological and Environmental Sciences & Engineering Division (BESE), King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.

Förderung

  • Ministry of Education - Kingdom of Saudi Arabia

Zitieren

APA

Al-Faze, R., Ahmed, H. A., El-Atawy, M. A., Zagloul, H., Alshammari, E. M., Jaremko, M., Emwas, A. H., Nabil, G. M., & Hanna, D. H. (2025). Mitochondrial dysfunction route as a possible biomarker and therapy target for human cancer. Biomedical Journal, 48(1), 100714. https://doi.org/10.1016/j.bj.2024.100714

Vancouver

Al-Faze R, Ahmed HA, El-Atawy MA, Zagloul H, Alshammari EM, Jaremko M, et al. Mitochondrial dysfunction route as a possible biomarker and therapy target for human cancer. Biomedical Journal. 2025;48(1):100714. doi:10.1016/j.bj.2024.100714

BibTeX
@article{AlFaze2025,
  author = {Al-Faze, Rawan and Ahmed, Hoda A and El-Atawy, Mohamed A and Zagloul, Hayat and Alshammari, Eida M and Jaremko, Mariusz and Emwas, Abdul-Hamid and Nabil, Gehan M and Hanna, Demiana H},
  title = {Mitochondrial dysfunction route as a possible biomarker and therapy target for human cancer},
  journal = {Biomedical Journal},
  year = {2025},
  volume = {48},
  number = {1},
  pages = {100714},
  doi = {10.1016/j.bj.2024.100714}
}
Kostenlos starten →